Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,306 INR | -2.87% | -6.59% | -11.13% |
2023 | Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
2023 | Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
Sales 2022 | 1.84B 22.05M | Sales 2023 | 2.27B 27.24M | Capitalization | 6.03B 72.29M |
---|---|---|---|---|---|
Net income 2022 | 248M 2.97M | Net income 2023 | 307M 3.68M | EV / Sales 2022 | 2.98 x |
Net Debt 2022 | 32.79M 393K | Net Debt 2023 | 11.68M 140K | EV / Sales 2023 | 2.66 x |
P/E ratio 2022 |
21.9
x | P/E ratio 2023 |
19.6
x | Employees | 315 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.07% |
1 day | -2.87% | ||
1 week | -6.59% | ||
Current month | +5.88% | ||
1 month | +7.25% | ||
3 months | -5.13% | ||
6 months | +44.35% | ||
Current year | -11.13% |
Managers | Title | Age | Since |
---|---|---|---|
Rahul Batra
CEO | Chief Executive Officer | 40 | 01/14/01 |
Varun Batra
CEO | Chief Executive Officer | 38 | 01/14/01 |
Nipun Arora
DFI | Director of Finance/CFO | 39 | 05/21/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Balwant Singh
BRD | Director/Board Member | 54 | 01/14/01 |
Varun Batra
CEO | Chief Executive Officer | 38 | 01/14/01 |
Rahul Batra
CEO | Chief Executive Officer | 40 | 01/14/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1,306 | -2.87% | 4,800 |
25/24/25 | 1,345 | -2.11% | 1,200 |
24/24/24 | 1,374 | +3.29% | 1,400 |
23/24/23 | 1,330 | -4.04% | 4,700 |
22/24/22 | 1,386 | -0.88% | 3,100 |
Delayed Quote NSE India S.E., April 26, 2024 at 05:13 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-11.13% | 151M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- BETA Stock